MXPA04000384A - Formulacion de medicamento que contiene antagonista de ltb4. - Google Patents

Formulacion de medicamento que contiene antagonista de ltb4.

Info

Publication number
MXPA04000384A
MXPA04000384A MXPA04000384A MXPA04000384A MXPA04000384A MX PA04000384 A MXPA04000384 A MX PA04000384A MX PA04000384 A MXPA04000384 A MX PA04000384A MX PA04000384 A MXPA04000384 A MX PA04000384A MX PA04000384 A MXPA04000384 A MX PA04000384A
Authority
MX
Mexico
Prior art keywords
formulation containing
pharmaceutical formulation
ltb4 antagonist
ltb4
antagonist
Prior art date
Application number
MXPA04000384A
Other languages
English (en)
Inventor
Becker Robert
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10206241A external-priority patent/DE10206241A1/de
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of MXPA04000384A publication Critical patent/MXPA04000384A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Psychiatry (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

La invencion se refiere a una nueva formulacion de medicamento que contiene un antagonista de LTB4 de la formula I (ver formula) en donde A, R1, R2, R3 y R4 presentan el significado indicado en la reivindicacion 1, asi como su empleo como medicamento.
MXPA04000384A 2001-07-14 2002-07-09 Formulacion de medicamento que contiene antagonista de ltb4. MXPA04000384A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10134377 2001-07-14
DE10206241A DE10206241A1 (de) 2001-07-14 2002-02-15 Arzneimittelformulierung enthaldend einen LTB Antagonisten
PCT/EP2002/007618 WO2003007922A2 (de) 2001-07-14 2002-07-09 Arzneimittelformulierung enthaltend einen ltb4 antagonisten

Publications (1)

Publication Number Publication Date
MXPA04000384A true MXPA04000384A (es) 2004-05-04

Family

ID=26009704

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04000384A MXPA04000384A (es) 2001-07-14 2002-07-09 Formulacion de medicamento que contiene antagonista de ltb4.

Country Status (17)

Country Link
EP (1) EP1408943B1 (es)
JP (1) JP2005502630A (es)
KR (1) KR100912196B1 (es)
CN (1) CN1298316C (es)
AT (1) ATE298564T1 (es)
AU (1) AU2002333235B2 (es)
BR (1) BR0211090A (es)
CA (1) CA2452357A1 (es)
ES (1) ES2244821T3 (es)
HU (1) HUP0401371A3 (es)
IL (1) IL159493A0 (es)
MX (1) MXPA04000384A (es)
NZ (1) NZ530973A (es)
PL (1) PL368613A1 (es)
RU (1) RU2004102399A (es)
UY (1) UY27376A1 (es)
WO (1) WO2003007922A2 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10232120A1 (de) 2002-07-16 2004-02-05 Fev Motorentechnik Gmbh Verfahren und Vorrichtung zum künstlichen Altern eines Kraftfahrzeugkatalysators
RS20050390A (en) * 2002-11-26 2008-04-04 Boehringer Ingelheim Pharma Gmbh. & Co.Kg., Pharmaceutical composition comprising a ltb4 antagonist and a cox-2 inhibitor or a combined cox 1/2 inhibitor
US20070237823A1 (en) * 2004-05-04 2007-10-11 Thomas Bock Solid Pharmaceutical Form Comprising and Ltb4 Antagonist
EP3623368A4 (en) 2017-05-12 2021-04-07 Riken CLASS A GPCR BINDING COMPOUND MODIFIER

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5451700A (en) * 1991-06-11 1995-09-19 Ciba-Geigy Corporation Amidino compounds, their manufacture and methods of treatment
ES2165122T3 (es) * 1992-02-05 2002-03-01 Boehringer Ingelheim Pharma Nuevos derivados de amidina, su preparacion y utilizacion como medicamentos con efecto antagonista de ltb4.
DE4424713A1 (de) * 1994-07-13 1996-01-18 Boehringer Ingelheim Kg Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe
DE19546452A1 (de) * 1995-12-13 1997-06-19 Boehringer Ingelheim Kg Neue Phenylamidinderivate, Verfahren zu ihrer Herstelung und ihre Verwendung als Arzneimittel
DE19636689A1 (de) * 1996-09-10 1998-03-12 Boehringer Ingelheim Kg Neue Benzamidinderivate
DE19637123A1 (de) * 1996-09-12 1998-03-19 Boehringer Ingelheim Kg Neue Pyranosidderivate
DE19948428A1 (de) * 1999-10-07 2001-04-12 Boehringer Ingelheim Pharma Neuer LTB¶4¶-Antagonist, Verfahren zu dessen Herstellung und dessen Verwendung als Arzneimittel

Also Published As

Publication number Publication date
BR0211090A (pt) 2004-06-15
WO2003007922A2 (de) 2003-01-30
AU2002333235B2 (en) 2007-07-12
EP1408943A2 (de) 2004-04-21
EP1408943B1 (de) 2005-06-29
KR20040016988A (ko) 2004-02-25
KR100912196B1 (ko) 2009-08-14
RU2004102399A (ru) 2005-05-27
ATE298564T1 (de) 2005-07-15
UY27376A1 (es) 2003-02-28
HUP0401371A2 (hu) 2004-12-28
CA2452357A1 (en) 2003-01-30
HUP0401371A3 (en) 2010-01-28
NZ530973A (en) 2006-07-28
CN1298316C (zh) 2007-02-07
IL159493A0 (en) 2004-06-01
ES2244821T3 (es) 2005-12-16
WO2003007922A3 (de) 2003-04-17
PL368613A1 (en) 2005-04-04
JP2005502630A (ja) 2005-01-27
CN1527705A (zh) 2004-09-08

Similar Documents

Publication Publication Date Title
SE0001899D0 (sv) New compounds
HK1048990A1 (en) Novel compounds.
PL366198A1 (en) Novel compounds
AP9801169A0 (en) N-hydroxy-B-sulfonyl propionamide derivatives.
GB0003154D0 (en) Novel compounds
MXPA04000756A (es) Nuevos compuestos.
WO2002032898A3 (de) Neue anticholinergika, verfahren zu deren herstellung und deren verwendung als arzneimittel
GB0004128D0 (en) Novel compounds
MY127144A (en) New anticholinergics which may be used as medicaments as well as processes for preparing them
AP1614A (en) New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-bacterial agents.
MY137535A (en) New pyrrolidinium derivatives
MXPA02007942A (es) Derivados de pirrolopirimidinona, procesos de preparacion y uso.
MY127718A (en) Dolastatin 10 derivatives.
SE9904505D0 (sv) Novel compounds
HK1084941A1 (en) Compounds and their use
MY133969A (en) Indoloquinazolinones
SE9902765D0 (sv) Novel compounds
IL140070A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
SE0101038D0 (sv) Novel compounds
WO2002050067A3 (en) Pharmaceutical heterocyclic compounds
MY134026A (en) ?-carboline derivatives and its pharmaceutical use against depression and anxiety
MY136297A (en) Piperazine derivatives having sst1 antagonistic activity
CA2412596A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
MXPA04001419A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson.
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.

Legal Events

Date Code Title Description
FG Grant or registration